ライフサイエンスコーパス: 99mTc

1 99mTc and 188Re are generator produced, an advantage for

2 99mTc-(N-ethoxy-N-ethyl-dithiocarbamato)nitrido (N-NOET)

3 99mTc-annexin V can detect collagen-induced immune arthr

4 99mTc-anti-CD56 is a promising tool for in vivo imaging

5 99mTc-C2A-GST had a radiochemical purity of >98% and rem

6 99mTc-DMSA late static planar imaging or SPECT is being

7 99mTc-DMSA SPECT, spiral CT, and MR imaging appear to be

8 99mTc-duramycin is a stable, low-molecular-weight PtdE-b

9 99mTc-duramycin is completely unmetabolized in vivo, and

10 99mTc-EC20 is a folate receptor (FR)-targeted imaging ag

11 99mTc-FBP16 displayed low target uptake and distribution

12 99mTc-FGF-1 serves as a new radiotracer to measure in vi

13 99mTc-Glucarate is an infarct-avid imaging agent with th

14 99mTc-Hn-bitistatin bound to stimulated platelets with a

15 99mTc-human IgG (Tc-HIG), injected into the hand dermis,

16 99mTc-Labeled annexin V has been used for the imaging of

17 99mTc-labeled imaging agent, Tc-99m-HL91, developed as a

18 99mTc-labeled LeuTech was prepared on site using a lyoph

19 99mTc-MAG3 renal scans were grossly abnormal in the allo

20 [99mTc-MAS3]-SDF-1alpha could be prepared in 2 h total wi

21 [99mTc-MAS3]-SDF-1alpha exhibits high specificity for CXC

22 99mTc-Mercaptoacetyltriglycine ((99m)Tc-MAG3) and (99m)T

23 99mTc-methylene diphosphonate (MDP) bone scanning was pe

24 99mTc-N-NOET was given during peak vasodilator stress 16

25 99mTc-radiolabeled annexin V was intravenously administe

26 99mTc-RP517 is a new leukotriene B4 (LTB4) receptor anta

27 99mTc-RP517 was injected intravenously in anesthetized,

28 99mTc-TP 850 was then injected through a lateral ear vei

29 [99mTc]oxotechnetium(V) complexes of amine-amide-dithiol

30 ging, and subsequently, 99mTc-labeled FGF-1 (99mTc-FGF-1) was imaged after i.v. injection.

31 and pathologic studies of simultaneous 123I/99mTc brain SPECT when compensating for all degrading ph

32 robe with three of these radionuclides (18F, 99mTc, and (111)In).

33 indices correlated well with technetium 99m (99mTc) diethylenetriaminepentaacetic acid (DTPA) clearan

34 In vitro binding assays of technetium 99m (99mTc)-labeled Cy7 tilmanocept were conducted at 4 degre

35 optotic cells in vitro, with technetium-99m (99mTc) as a radionuclide imaging agent that can localize

36 been shown to stably complex technetium-99m (99mTc) for nuclear imaging and radiorhenium (186/188Re)

37 a single stable chelate with technetium-99m (99mTc) oxotechnetate.

38 tries have the capability of assembling 99Mo-99mTc generators, and 2 countries produce 99mTc from nuc

39 99Mo/99mTc generators were placed in the negative-pressure cl

40 A 99mTc-labeled peptide (NC100692) targeted at alpha(v)bet

41 We describe a 99mTc-labeled SDF-1alpha radiotracer that can be used as

42 We evaluated a 99mTc-labeled peptide (NC100692) targeted at alpha(v)bet

43 se studies show the feasibility of imaging a 99mTc-labeled peptide's binding to a reporter receptor a

44 Carlo simulations and real acquisition of a 99mTc cardiac phantom were performed under comparable co

45 study were to efficiently target NKs using a 99mTc-anti-CD56 and to image human NK trafficking in SCI

46 aneous assessment of brain perfusion using a 99mTc-labeled tracer and neurotransmission using an 123I

47 1, 2; R = Et, n-Bu) ligand was mixed with a [99mTc]oxotechnetium(V)-glucoheptonate precursor to make

48 )-glucoheptonate precursor to make the AADT-[99mTc]oxotechnetium(V) complexes in nearly quantitative

49 ages of various solid tumors that accumulate 99mTc-EC20 in vivo and to correlate 99mTc-EC20 uptake wi

50 atography (GFC) using high-specific-activity 99mTc-S-acetylmercaptoacetyltriserine-N-hydroxysuccinimi

51 istry, we produced a high-specific-activity, 99mTc-labeled, PSMA-targeted small molecule and demonstr

52 Thus, high-affinity 99mTc-labeled ACE inhibitor has been designed with poten

53 ) B16F10 cells; 14 days later, 2 hours after 99mTc-1 administration, lung uptake of 2.83 +/- 0.21%, 3

54 Two hours after 99mTc-sestamibi injection (5-10 mCi [185-370 MBq]), imag

55 ography/CT imaging studies with an analogous 99mTc-labeled MMP-targeted radiotracer (99mTc-RP805) and

56 des radiolabeled with 111In, 90Y, 177Lu, and 99mTc.

57 The 99mTc(NS3)(CN-AVP) and 99mTc(NS3)(CN-AVP(an)) ability of binding to small-cell

58 NDP]; 99mTc-CGCG-NDP; 99mTc-Gly11-CCMSH; and 99mTc-Nle11-CCMSH.

59 d for the preparation of MAG3-conjugated and 99mTc-radiolabeled biomolecules that required elevated t

60 report here an improved MAG3 conjugation and 99mTc radiolabeling method capable of generating high ra

61 le was divided into 72 segments for flow and 99mTc-RP517 uptake analysis.

62 difference was found between MR imaging and 99mTc MIBI scintigraphy for sensitivity (P =.7).

63 MR imaging and 99mTc MIBI scintigraphy have similarly good sensitivity

64 positive predictive value of MR imaging and 99mTc MIBI scintigraphy were compared with each other an

65 persistent HPT after surgery, MR imaging and 99mTc MIBI study findings were retrospectively reviewed

66 e relationship between 125I-iodorotenone and 99mTc-sestamibi washout was complex and depended on elap

67 properties of 64Cu-L1, 64Cu-L2, 64Cu-L3, and 99mTc-Sestamibi were evaluated in athymic nude mice bear

68 clearances of o-131I-iodohippurate (OIH) and 99mTc-labeled DD- and LL-ethylenedicysteine (EC).

69 9mTc-sulfur colloid bone marrow scanning and 99mTc-diphosphonate bone scanning.

70 ated azomycin galactopyranoside (IAZGP) and [99mTc]HL-91 were simultaneously administered to 26 anima

71 studied a promising new monoclonal antibody, 99mTc-labeled anti-CD 15 (LeuTech; Palatin Technologies,

72 the C2A domain of synaptotagmin I and assess 99mTc-C2A-GST (GST is glutathione S-transferase) using a

73 r arm was inflated to 60 mmHg (Pcuff) before 99mTc-HIG injection and maintained for>>ttransit.

74 an inverse exponential relationship between 99mTc-RP517 uptake and occlusion flow (r=0.73).

75 Relationships between 99mTc-sestamibi and 201Tl RRFs and microsphere RRFs were

76 , comparison biodistribution studies between 99mTc and 188Re (39) showed a good correlation between t

77 ulated normal and pathologic studies of both 99mTc and 123I activity estimates were very close with A

78 easurements were obtained using a collimated 99mTc flood source in conjunction with planar emission s

79 of ischemia-reperfusion (IR) and to compare 99mTc-sestamibi imaging and triphenyltetrazolium chlorid

80 suggest that the novel vasopressin conjugate 99mTc(NS3)(CN-AVP(an)) is a desirable compound for imagi

81 cumulate 99mTc-EC20 in vivo and to correlate 99mTc-EC20 uptake with immunohistochemistry (IHC) analys

82 oncentrations of 99mTc-Cardiolite or decayed 99mTc-Cardiolite (cell survival, > or =88%) induces an a

83 related to the radiation effects of decaying 99mTc but to chemical(s) present in the 99mTc-Cardiolite

84 immunization with type II collagen decreased 99mTc-annexin V uptake by 3- to 6-fold compared with con

85 ed detection of lesions or falsely decreased 99mTc-MDP activity at metastatic bone tumor sites.

86 Diuretic 99mTc-mercaptoacetyltriglycine (MAG3) dynamic scintireno

87 enal function was evaluated first by dynamic 99mTc-MAG3 imaging, and subsequently, 99mTc-labeled FGF-

88 al of this study was to develop and evaluate 99mTc-duramycin as a novel molecular probe for imaging P

89 We evaluated 99mTc-labeled anti-CD15 immunoglobulin M monoclonal anti

90 r separate, dual-isotope rest 201Tl-exercise 99mTc-sestamibi SPECT in 36 patients with <5% before-sca

91 1In (FBP15, 111In-DOTA-MA), or 99mTc (FBP16, 99mTc(CO)3-DETA-PA), respectively.

92 Finally, 99mTc-duramycin binding to acute cell death in vivo was

93 For 99mTc with AW + OSEM, the bias was 60% in the corpus cal

94 For 99mTc-C2A-GST, radioactivity uptake in the area at risk

95 The internal radiation dose for 99mTc-pertechnetate was calculated on the basis of exper

96 Thirty-seven SLE patients were referred for 99mTc-ethyl cysteinate dimer SPECT brain imaging because

97 nstitutional sensitivity and specificity for 99mTc-sestamibi breast imaging were 75.4% and 82.7%, res

98 racer and compare the results with those for 99mTc-sestamibi.

99 Twenty-four 99mTc and 123I activity distributions were simulated on

100 size and severity of myocardial defects from 99mTc sestamibi cardiac phantom studies performed on mul

101 diation-absorbed dose to various organs from 99mTc-sulfur colloid (TSC) LSG using standard internal a

102 n the BNT correlated with low frontotemporal 99mTc-HMPAO (Spearman r = 0.97, P = 0.004) in the 5 pati

103 ed for rest-stress electrocardiography-gated 99mTc-sestamibi MPS with AC were considered.

104 teers were injected twice with 0.96-1.15 GBq 99mTc-labeled hexamethylpropylene amine oxime.

105 Hot-spot and line sources with very high 99mTc activities were imaged.

106 Higher 99mTc yields can be obtained with medium-energy cyclotro

107 rcaptoacetyltriserine-N-hydroxysuccinimide ([99mTc-MAS3]-NHS) prepared by solid-phase preloading.

108 ed with MRFP and radionuclide SPECT imaging (99mTc-sestamibi and 201Tl).

109 Thus, the difference in 99mTc-N-NOET uptake between the 2 groups was less than e

110 In this group, a significant reduction in 99mTc-FGF-1 renal binding was measured by imaging analys

111 accumulation was estimated using inactivated 99mTc-C2A-GST.

112 Tumors with increased 99mTc-EC20 uptake were identified in 68% of patients, an

113 , converts readily available and inexpensive 99mTc-pertechnetate into a chemically pure complex, with

114 re measured by gamma scintigraphy of inhaled 99mTc Fe2O3.

115 Intravenously injected 99mTc-duramycin has favorable pharmacokinetic and biodis

116 on, and clearance of intravenously injected [99mTc-MAS3]-SDF-1alpha were quantified in Sprague-Dawley

117 An injectible, 99mTc-labeled, murine immunoglobulin M antibody to stage

118 After intravenous injection, 99mTc-labeled SDF-1alpha displays a blood half-life of 2

119 es were radiolabeled with the SPECT isotopes 99mTc or 111In.

120 as prepared on site using a lyophilized kit, 99mTc-labeled pertechnetate, and 2 different incubation

121 aphy/computed tomography revealed high-level 99mTc-tilmanocept uptake across 20.4% of the aortic surf

122 Among all subjects, aortic high-level 99mTc-tilmanocept uptake was related to noncalcified aor

123 cystitis (CAC) patients received 111-185 MBq 99mTc-mebrofenin as a hepatic bile marker.

124 A total of 30 mCi 99mTc-sestamibi was injected at one minute into the spee

125 stfurosemide 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) scans.

126 We also did a metastable 99mTc-labelled dimercaptosuccinic acid (DMSA) assay and

127 alpha-MSH [125I-(Tyr2)-NDP]; 99mTc-CGCG-NDP; 99mTc-Gly11-CCMSH; and 99mTc-Nle11-CCMSH.

128 )-[Nle4, D-Phe7]alpha-MSH [125I-(Tyr2)-NDP]; 99mTc-CGCG-NDP; 99mTc-Gly11-CCMSH; and 99mTc-Nle11-CCMSH

129 hat technetium-99m-labeled AADT-(CH2)2-NEt2 (99mTc-1) has the highest tumor uptake and other favorabl

130 with previous estimates using nonstabilized 99mTc-exametazime-labeled leukocytes.

131 s: (a) leukocytes labeled with nonstabilized 99mTc-exametazime, (b) leukocytes labeled with stabilize

132 ian PO2 and the avidity of beta-D-IAZGP nor [99mTc]HL-91 in this tumor model.

133 ection images from 8 patients who had normal 99mTc-sestamibi SPECT findings.

134 UTP) incorporation, nuclear accumulations of 99mTc-labeled DNAs, and messenger RNA (mRNA) transcripti

135 agnoses to define the diagnostic accuracy of 99mTc-sestamibi breast imaging.

136 multicenter trial the diagnostic accuracy of 99mTc-sestamibi in women with suspected breast cancer an

137 e was > or =95%, with a specific activity of 99mTc of 47.5 TBq/mmol.

138 carcinoma up to 24 h after administration of 99mTc-EC-C225.

139 The administration of 99mTc-EC20 was well tolerated.

140 The alteration of 99mTc-labeled diethylenetriaminepentaacetic acid (DTPA)

141 trophils (n= 4) with a fluorescent analog of 99mTc-RP517, [F]-RP517.

142 Planar anterior imaging analysis of 99mTc-[D(C8)lisinopril] corroborated these data.

143 In vivo application of 99mTc-tilmanocept single-photon emission computed tomogr

144 low hepatic background, the avid binding of 99mTc-duramycin to the infarcted myocardium quickly beco

145 Reduced renal binding of 99mTc-FGF-1 in the allogeneic transplanted kidney was co

146 The mean binding of 99mTc-TP 850 to human, dog, and rabbit fibrin was 46% +/

147 ce, pharmacokinetics, and biodistribution of 99mTc-duramycin were measured in rats.

148 The clearance of 99mTc-mercaptoacetyltriglycine (MAG3) is less than the c

149 ies (CIM), which included the combination of 99mTc-methylene diphosphonate scintigraphy, CT, or MRI.

150 cells to low extracellular concentrations of 99mTc-Cardiolite or decayed 99mTc-Cardiolite (cell survi

151 Solid-phase conversion of 99mTc-pertechnetate to 99mTc-MAS3-NHS (MAS3 is S-acetylm

152 ribes a simple cartridge-based conversion of 99mTc-pertechnetate to a useful, preloaded NHS ester int

153 functions sequentially with a single dose of 99mTc-mebrofenin.

154 is study assessed the radiation dosimetry of 99mTc-labeled ethylene dicysteine (EC) C225 (EC-C225), a

155 superior image quality in the evaluation of 99mTc-DMSA renal SPECT data, with the potential for mark

156 enone was much higher than the extraction of 99mTc-sestamibi (0.84 +/- 0.05 vs. 0.48 +/- 0.10, respec

157 s were obtained 2-3 hours after injection of 99mTc-DMSA.

158 sions in vitro, and intravenous injection of 99mTc-labeled anti-MMR nanobodies successfully targeted

159 MAG3, OIH, and the DD, LL, and DL isomers of 99mTc-EC were measured in an isolated perfused rat kidne

160 le biodistribution and clearance kinetics of 99mTc-RP805 for in vivo cardiac imaging, with robust ret

161 Additionally, a higher level of 99mTc-1 accumulation was seen 17 days after tumor cell i

162 determined the compartmental localization of 99mTc-FGF-1.

163 hy, were injected with 403.3 +/- 48.1 MBq of 99mTc-annexin V, underwent SPECT, and were sacrificed.

164 imaging was achieved by injecting 5.5 MBq of 99mTc-anti-CD56 mAb in SCID mice bearing ARO tumor xenog

165 his report, the tumor targeting mechanism of 99mTc-CCMSH was studied and compared with four other rad

166 an explanation for the observed migration of 99mTc-labeled antisense DNA into the nucleus.

167 ional six mice were injected with 31 nmol of 99mTc-labeled Cy7 tilmanocept (high-dose group) to satur

168 Six mice were injected with 0.11 nmol of 99mTc-labeled Cy7 tilmanocept (low-dose group); an addit

169 Observation of 99mTc-sestamibi tumor uptake provided the impetus for it

170 y artery disease (CAD) before performance of 99mTc-sestamibi stress-rest myocardial perfusion SPECT.

171 ; for comparison, unscattered (U) photons of 99mTc and 123I were recorded.

172 Cyclotron production of 99mTc is a promising route to supply 99mTc radiopharmace

173 A unique property of 99mTc-RP517 is its ability to label white blood cells in

174 y, evaluation of the radioisotopic purity of 99mTc produced at medium energy (20-24 MeV) and its impa

175 Radioisotopic purity of 99mTc produced with 99.03% enriched 100Mo was greater th

176 The radioisotopic purity of 99mTc produced with 99.815% enriched 100Mo was 99.98% or

177 ethod for absolute in vivo quantification of 99mTc-sestamibi uptake in a porcine model of myocardial

178 A <6% increase in whole-body retention of 99mTc-MDP was seen on the initial postalendronate scan c

179 increase in relative myocardial retention of 99mTc-RP805 in MI regions (Ctrl, 102+/-9%; 1 week, 351+/

180 This pilot study of 99mTc-EC20 scintigraphy indicates that the agent is safe

181 Unique glomerular targeting of 99mTc-FGF-1 in the transplanted kidney provides addition

182 including a recently perfected technique of 99mTc-labeled annexin V in live animals followed by phos

183 s approximately 40 times better than that of 99mTc-Sestamibi at 120 min postinjection.

184 e closely related to flow than were those of 99mTc-sestamibi (P < 0.001 for both comparisons).

185 125I-iodorotenone were greater than those of 99mTc-sestamibi, making 125I-iodorotenone the superior f

186 the time of tissue sampling and the time of 99mTc-EC20 imaging, the heterogeneous expression of FR i

187 < 0.002) nearly 3-fold increase in uptake of 99mTc-annexin V in the front foot pads, rear toes, rear

188 he 22 injured vessels showed focal uptake of 99mTc-annexin V in vivo (scan positive), and 9 injured v

189 The uptake of 99mTc-C2A-GST within the area at risk was quantified by

190 decreasing the nonspecific kidney uptake of 99mTc-CCMSH, substitution of Lys11 in CCMSH with Gly11 o

191 The specific uptake of 99mTc-duramycin in apoptotic cells, compared with that i

192 The uptake of 99mTc-EC20 in tumors was scored as no uptake, mild uptak

193 nate did not competitively inhibit uptake of 99mTc-MDP in the skeleton or tumor metastasis.

194 Evaluation of [99mTc]oxotechnetium(V) complexes of the amine-amide-dith

195 t on 125I-iodorotenone net retention than on 99mTc-sestamibi net retention 1 min after tracer injecti

196 ves labeled with either with 68Ga, 111In, or 99mTc as thrombus imaging agents for PET and SPECT.

197 Ga-NODAGA), 111In (FBP15, 111In-DOTA-MA), or 99mTc (FBP16, 99mTc(CO)3-DETA-PA), respectively.

198 for radiodiagnostic purposes (99mTc P829 or 99mTc depreotide) were reoptimized for radiotherapy of t

199 Fifty sequential pediatric patient 99mTc-DMSA SPECT studies of 98 kidneys were retrospectiv

200 Extracted sodium pertechnetate 99mTc met all provisional quality standards.

201 ities was below 10% for sodium pertechnetate 99mTc produced from 99.03% 100Mo if injected up to 6 h a

202 loss, and the resulting sodium pertechnetate 99mTc was assayed for chemical, radiochemical, and radio

203 Clinical-grade sodium pertechnetate 99mTc was produced with a cyclotron at medium energies.

204 al obstruction using pre- and postfurosemide 99mTc-MAG3 renal scans, at a standardized expert level.

205 patients undergoing pre- and postfurosemide 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) scans.

206 ith some coronary flow reserve preservation, 99mTc-N-NOET imaging can detect residual coronary stenos

207 The multireporter probe 99mTc-labeled Cy7 tilmanocept exhibits in vitro and in v

208 As an adjunct to current procedures, 99mTc-sestamibi breast imaging may contribute to patient

209 Mo-99mTc generators, and 2 countries produce 99mTc from nuclear reactors.

210 atory framework for using cyclotron-produced 99mTc in routine clinical practice.

211 olution and contrast with cyclotron-produced 99mTc were equivalent to those obtained with 99mTc elute

212 ously designed for radiodiagnostic purposes (99mTc P829 or 99mTc depreotide) were reoptimized for rad

213 mor ratios seen with a directly radiolabeled 99mTc-anti-anticarcinoembryonic antigen Fab' at this sam

214 The new radiopharmaceutical 99mTc-EC-C225 appears to have reasonable dosimetric prop

215 ng the IDDS system of the drug, radiotracer (99mTc-DTPA) solution was injected into the pump reservoi

216 gous 99mTc-labeled MMP-targeted radiotracer (99mTc-RP805) and 201Tl demonstrated favorable biodistrib

217 Mice in the control groups received 99mTc-F(ab')2 but not the conjugate.

218 o receive C225 in a phase III trial received 99mTc-EC-C225 before their 20-mg test dose or after thei

219 als of this study were to determine relative 99mTc-RP517 binding to human leukocyte subtypes and the

220 After reperfusion, 99mTc-RP517 uptake correlated with myeloperoxidase and w

221 The resultant 99mTc-EC20 data were analyzed for correlation with the e

222 In the same 15 segments, 99mTc-RP517 uptake was highly correlated with the neutro

223 solute activity quantitation in simultaneous 99mTc/123I SPECT.

224 eled with either nonstabilized or stabilized 99mTc-exametazime) in this study.

225 zime, (b) leukocytes labeled with stabilized 99mTc-exametazime containing 250 microg methylene blue,

226 , and (c) leukocytes labeled with stabilized 99mTc-exametazime containing 500 microg methylene blue.

227 count of leukocytes labeled with stabilized 99mTc-exametazime.

228 Rest and dipyridamole (DP)-stress 99mTc sestamibi single-photon emission computed tomograp

229 201TI (111-167 MBq, 35 s/projection)-stress 99mTc-sestamibi (925-1480 MBq, 25 s/projection) separate

230 ynamic 99mTc-MAG3 imaging, and subsequently, 99mTc-labeled FGF-1 (99mTc-FGF-1) was imaged after i.v.

231 tion of 99mTc is a promising route to supply 99mTc radiopharmaceuticals.

232 ve much lower heart uptake (<0.6% ID/g) than 99mTc-Sestamibi ( approximately 18% ID/g) at >30 min p.i

233 -iodorotenone was significantly greater than 99mTc-sestamibi net retention at 1 min (0.77 +/- 0.08 vs

234 al in vitro and ex vivo assessment show that 99mTc-1 has high and specific uptake in melanoma metasta

235 ovine serum albumin as a control showed that 99mTc-annexin V localization was specific.

236 The 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative was

237 The 99mTc(NS3)(CN-AVP) and 99mTc(NS3)(CN-AVP(an)) ability of

238 The 99mTc-labeled conjugates of the vasopressin (AVP) peptid

239 binding to human leukocyte subtypes and the 99mTc-RP517 uptake pattern in canine myocardium where in

240 7 quantitative parameters extracted from the 99mTc-MAG3 scans of 100 potential renal donors.

241 ying 99mTc but to chemical(s) present in the 99mTc-Cardiolite kit.

242 In vitro cell uptake of the 99mTc complexes in intact B16 murine melanoma cells at 3

243 The in vivo biodistribution of the 99mTc(I) derivative was evaluated in virgin female C57BL

244 ated that the postpurification purity of the 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative was

245 ined by examining the biodistribution of the 99mTc-[D(C8)lisinopril] analog in rats with and without

246 ected into the renal artery with each of the 99mTc-tracers.

247 Within tumors, the 99mTc-labeled nanobodies specifically labeled MMR+ TAMs,

248 ade among GPI monomer, GPI trimer, and their 99mTc-derivatives.

249 ation between technetium Tc 99m tilmanocept (99mTc-tilmanocept) and CD206+ macrophages ex vivo.

250 nsisting of the vitamin folate conjugated to 99mTc.

251 d-phase conversion of 99mTc-pertechnetate to 99mTc-MAS3-NHS (MAS3 is S-acetylmercaptoacetyltriserine)

252 The estimated dose increase relative to 99mTc without any radionuclidic impurities was below 10%

253 single-photon emission computed tomography, 99mTc single-photon emission computed tomography with se

254 ave characterized a novel neutral tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for

255 a new structural class of neutral tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivatives fo

256 ange, 1-16 y; mean age, 5.4 y) who underwent 99mTc-DMSA SPECT were measured independently by 2 observ

257 control rats was shown clearly, with uniform 99mTc-sestamibi distribution and 100% TTC staining for v

258 cuff was then lowered in 10 mmHg steps until 99mTc-HIG began to flow under the cuff to the axilla, in

259 We used 99mTc-annexin V and autoradiography to study the extent

260 We used 99mTc-radiolabeled annexin V and radionuclide gamma came

261 ternative hypothesis, a novel approach using 99mTc-labeled antisense DNA as a probe of total mRNA fro

262 There is great potential for using 99mTc-labeled peptides for imaging gene transfer with th

263 g and intensity of apoptosis in joints using 99mTc-labeled annexin V, an in vivo marker of apoptosis,

264 eased more than 5-fold, as quantified using [99mTc-MAS3]-SDF-1alpha and confirmed using confocal immu

265 tion was also less affected by flow than was 99mTc-sestamibi (P < 0.001).

266 iodohippurate (OIH) was used; and 1995, when 99mTc-mercaptoacetyltriglycine (MAG3) was used.

267 One hundred and forty SPECT images (70 with 99mTc and 70 with 201TI) were acquired using a triple-he

268 led to identify perfusion abnormalities with 99mTc-ethyl cysteinate dimer in a patient with Susac syn

269 ied phantom SPECT defect sizes acquired with 99mTc correlated well with actual calculated defect size

270 te chemotactic peptide-1, and apoptosis with 99mTc annexin V.

271 l of this study was to label bitistatin with 99mTc and assess its potential for imaging thrombi and e

272 in underwent 93 sequential examinations with 99mTc-sulfur colloid bone marrow scanning and 99mTc-diph

273 deoxyglucose (FDG), receptor expression with 99mTc monocyte chemotactic peptide-1, and apoptosis with

274 In vivo imaging with 99mTc-EC20 identified approximately two thirds of patien

275 esion of > or =1.5 cm underwent imaging with 99mTc-EC20.

276 d with the cytoplasm in cells incubated with 99mTc-labeled antisense DNA.

277 ate results in competitive interference with 99mTc-labeled bone scanning reagents.

278 charged ligands are difficult to label with 99mTc and to purify.

279 e acetone hydrazone (HYNIC) and labeled with 99mTc using a coordination chemistry involving tricine-p

280 repared, HYNIC-annexin V can be labeled with 99mTc, a widely available gamma-radiation-emitting radio

281 n vitro stability of leukocytes labeled with 99mTc-exametazime.

282 ising its biologic activity and labeled with 99mTc.

283 :1), and F(ab')2 of the MAb was labeled with 99mTc.

284 requires about 4 h, while the labeling with 99mTc requires about an additional 30 min.

285 After labeling with 99mTc via 2-iminothiolane thiolation, radiochemical puri

286 mmercially available probe was measured with 99mTc and compared with the results with a solid-state p

287 he gamma-detection sensitivity measured with 99mTc in gamma mode (5.59 +/- 0.41 counts per second [cp

288 99mTc were equivalent to those obtained with 99mTc eluted from a conventional generator.

289 ivities (beta and photon) were obtained with 99mTc.

290 eved with 18F; the lowest were obtained with 99mTc.

291 ne-containing small molecule or peptide with 99mTc in 1 step, with high specific activity and without

292 timized peptide P2045 (39) radiolabeled with 99mTc exhibited increased tumor uptake ( approximately 2

293 oclonal antibody (mAb) was radiolabeled with 99mTc, and in vitro quality controls were performed to t

294 her optimization entailed radiolabeling with 99mTc and biodistribution in an AR42J xenograft mouse mo

295 ecules for the purpose of radiolabeling with 99mTc for gamma detection or single photon emission comp

296 (99m)Tc-C2A-GST, and acute-infarct rats with 99mTc-C2A-GST-NHS (NHS is N-hydroxy succinimide), respec

297 enal diuretic scintirenographic studies with 99mTc-mercaptoacetyltriglycine (MAG3) were reviewed and

298 The early results of imaging tumors with 99mTc-VIP are promising and warrant further study.

299 s (range, 32%-59%) also correlated well with 99mTc-DTPA radionuclide measurements (r = 0.76); differe

300 at Parkinson's disease can be detected with [99mTc]TRODAT by simply inspecting the images for uptake